0000950170-24-016216.txt : 20240216 0000950170-24-016216.hdr.sgml : 20240216 20240216115631 ACCESSION NUMBER: 0000950170-24-016216 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240213 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brooks Gabriel CENTRAL INDEX KEY: 0001997809 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38360 FILM NUMBER: 24646645 MAIL ADDRESS: STREET 1: C/O SOLID BIOSCIENCES INC. STREET 2: 500 RUTHERFORD AVENUE, THIRD FLOOR CITY: CHARLESTOWN STATE: MA ZIP: 02129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solid Biosciences Inc. CENTRAL INDEX KEY: 0001707502 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 900943402 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 RUTHERFORD AVENUE STREET 2: 3RD FLOOR CITY: CHARLESTOWN STATE: MA ZIP: 02129 BUSINESS PHONE: 617-337-4680 MAIL ADDRESS: STREET 1: 500 RUTHERFORD AVENUE STREET 2: 3RD FLOOR CITY: CHARLESTOWN STATE: MA ZIP: 02129 FORMER COMPANY: FORMER CONFORMED NAME: Solid Biosciences, LLC DATE OF NAME CHANGE: 20170524 4 1 ownership.xml 4 X0508 4 2024-02-13 false 0001707502 Solid Biosciences Inc. SLDB 0001997809 Brooks Gabriel C/O SOLID BIOSCIENCES INC. 500 RUTHERFORD AVENUE, THIRD FLOOR CHARLESTOWN MA 02129 false true false false Chief Medical Officer false Employee Stock Option (Right to Buy) 7.85 2024-02-13 4 A false 87500 0.00 A 2034-02-13 Common Stock 87500 87500 D Restricted Stock Units 2024-02-13 4 A false 43750 0.00 A Common Stock 43750 43750 D This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs"). The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. /s/ David Tyronne Howton as attorney-in-fact for Gabriel Brooks 2024-02-16